| A pharmacokinetic analysis program (MULTI) for microcomputer K Yamaoka, Y Tanigawara, T Nakagawa, T Uno Journal of pharmacobio-dynamics 4 (11), 879-885, 1981 | 3142 | 1981 |
| Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. K Ueda, N Okamura, M Hirai, Y Tanigawara, T Saeki, N Kioka, T Komano, ... Journal of Biological Chemistry 267 (34), 24248-24252, 1992 | 840 | 1992 |
| Human P-glycoprotein transports cyclosporin A and FK506. T Saeki, K Ueda, Y Tanigawara, R Hori, T Komano Journal of Biological Chemistry 268 (9), 6077-6080, 1993 | 831 | 1993 |
| Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). Y Tanigawara, N Okamura, M Hirai, M Yasuhara, K Ueda, N Kioka, ... Journal of Pharmacology and Experimental Therapeutics 263 (2), 840-845, 1992 | 435 | 1992 |
| Role of P-glycoprotein in drug disposition Y Tanigawara Therapeutic drug monitoring 22 (1), 137-140, 2000 | 320 | 2000 |
| Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure M Watanabe, Y Horai, SM Houten, K Morimoto, T Sugizaki, E Arita, ... Journal of Biological Chemistry 286 (30), 26913-26920, 2011 | 289 | 2011 |
| Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients K Kiyotani, T Mushiroda, CK Imamura, N Hosono, T Tsunoda, M Kubo, ... Journal of Clinical Oncology 28 (8), 1287-1293, 2010 | 279 | 2010 |
| Unpredicted Clinical Pharmacology of UCN-01 Caused by Specific Binding to Human α1-Acid Glycoprotein E Fuse, H Tanii, N Kurata, H Kobayashi, Y Shimada, T Tamura, Y Sasaki, ... Cancer Research 58 (15), 3248-3253, 1998 | 257 | 1998 |
| CYP2C19 genotype–related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori Y Tanigawara, N Aoyama, T Kita, K Shirakawa, F Komada, M Kasuga, ... Clinical Pharmacology & Therapeutics 66 (5), 528-534, 1999 | 240 | 1999 |
| Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug … K Matsumoto, Y Takesue, N Ohmagari, T Mochizuki, H Mikamo, M Seki, ... Journal of Infection and Chemotherapy 19, 365-380, 2013 | 225 | 2013 |
| Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection M Inoue, K Takeda, K Morita, M Yamada, Y Tanigawara, Y Oguchi American journal of ophthalmology 138 (6), 1046-1048, 2004 | 203 | 2004 |
| A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures—a randomized, active comparator, double-blind study T Matsumoto, M Ito, Y Hayashi, T Hirota, Y Tanigawara, T Sone, ... Bone 49 (4), 605-612, 2011 | 201 | 2011 |
| CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects T Sakai, N Aoyama, T Kita, T Sakaeda, K Nishiguchi, Y Nishitora, T Hohda, ... Pharmaceutical research 18, 721-727, 2001 | 193 | 2001 |
| Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose H Kenmotsu, Y Tanigawara Cancer science 106 (5), 497-504, 2015 | 167 | 2015 |
| Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. R Hori, N Okamura, T Aiba, Y Tanigawara Journal of Pharmacology and Experimental therapeutics 266 (3), 1620-1625, 1993 | 159 | 1993 |
| A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial T Matsumoto, T Miki, H Hagino, T Sugimoto, S Okamoto, T Hirota, ... The Journal of Clinical Endocrinology & Metabolism 90 (9), 5031-5036, 2005 | 152 | 2005 |
| Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney. N Okamura, M Hirai, Y Tanigawara, K Tanaka, M Yasuhara, K Ueda, ... Journal of Pharmacology and Experimental Therapeutics 266 (3), 1614-1619, 1993 | 144 | 1993 |
| Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic … N Shimasaki, T Mori, H Samejima, R Sato, H Shimada, N Yahagi, C Torii, ... Journal of pediatric hematology/oncology 28 (2), 64-68, 2006 | 139 | 2006 |
| Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug … Y Hamada, I Tokimatsu, H Mikamo, M Kimura, M Seki, S Takakura, ... Journal of Infection and Chemotherapy 19 (3), 381-392, 2013 | 129 | 2013 |
| P‐glycoprotein‐mediated transcellular transport of MDR‐reversing agents T Saeki, K Ueda, Y Tanigawara, R Hori, T Komano FEBS letters 324 (1), 99-102, 1993 | 123 | 1993 |
